MARKET WIRE NEWS

The Longevity Shift: Valuing The Extension Of Healthy Human Life

Source: SeekingAlpha

2026-05-21 13:20:00 ET

By Shea Wihlborg, PhD, Research Analyst, Multiomics

Introduction

Longevity - the length of human life - is the subject of growing scientific and commercial interest. Often associated with “anti-aging,” the word carries connotations of cosmetic products, speculative therapies, and unproven claims. In our view, this association should not distract from the scientific progress now underway in aging biology research. Advances in aging biology suggest that aging is not a single process that occurs uniformly with chronological age. Instead, biological aging involves the progressive dysregulation of many measurable biological mechanisms that reduce resilience, increase disease risk, and erode function over time....

Read the full article on Seeking Alpha

For further details see:

The Longevity Shift: Valuing The Extension Of Healthy Human Life
iShares Biotechnology ETF

NASDAQ: IBB

IBB Trading

-0.7% G/L:

$170.39 Last:

523,319 Volume:

$171.10 Open:

mwn-app Ad 300

IBB Latest News

June 02, 2026 04:10:00 pm
5 Biggest Biotechnology ETFs in 2026
June 22, 2025 11:52:00 am
(IBB) Long Term Investment Analysis

IBB Stock Data

$8,450,686,995
48,799,948
N/A
N/A
US

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App